Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Nutr Sci Vitaminol (Tokyo) ; 61(2): 188-94, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26052151

RESUMEN

Muscle atrophy is a complex process that occurs as a consequence of various stress events. Muscle atrophy-associated genes (atrogenes) such as atrogin-1/MAFbx and MuRF-1 are induced early in the atrophy process, and the increase in their expression precedes the loss of muscle weight. Although antioxidative nutrients suppress atrogene expression in skeletal muscle cells, the inhibitory effects of flavonoids on inflammation-induced atrogin-1/MAFbx expression have not been clarified. Here, we investigated the inhibitory effects of flavonoids on lipopolysaccharide (LPS)-induced atrogin-1/MAFbx expression. We examined whether nine flavonoids belonging to six flavonoid categories inhibited atrogin-1/MAFbx expression in mouse C2C12 myotubes. Two major flavones, apigenin and luteolin, displayed potent inhibitory effects on atrogin-1/MAFbx expression. The pretreatment with apigenin and luteolin significantly prevented the decrease in C2C12 myotube diameter caused by LPS stimulation. Importantly, the pretreatment of LPS-stimulated myoblasts with these flavones significantly inhibited LPS-induced JNK phosphorylation in C2C12 myotubes, resulting in the significant suppression of atrogin-1/MAFbx promoter activity. These results suggest that apigenin and luteolin, prevent LPS-mediated atrogin-1/MAFbx expression through the inhibition of the JNK signaling pathway in C2C12 myotubes. Thus, these flavones, apigenin and luteolin, may be promising agents to prevent LPS-induced muscle atrophy.


Asunto(s)
Apigenina/farmacología , Luteolina/farmacología , Proteínas Musculares/metabolismo , Músculo Esquelético/efectos de los fármacos , Atrofia Muscular/metabolismo , Extractos Vegetales/farmacología , Proteínas Ligasas SKP Cullina F-box/metabolismo , Animales , Apigenina/uso terapéutico , Línea Celular , Flavonas/farmacología , Flavonas/uso terapéutico , Inflamación/metabolismo , Inflamación/prevención & control , Luteolina/uso terapéutico , Sistema de Señalización de MAP Quinasas , Ratones , Fibras Musculares Esqueléticas/efectos de los fármacos , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/citología , Músculo Esquelético/metabolismo , Atrofia Muscular/inducido químicamente , Atrofia Muscular/prevención & control , Fosforilación , Fitoterapia , Extractos Vegetales/uso terapéutico , Transducción de Señal
2.
J Nutr Sci Vitaminol (Tokyo) ; 59(4): 317-24, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24064732

RESUMEN

Proinflammatory cytokines are factors that induce ubiquitin-proteasome-dependent proteolysis in skeletal muscle, causing muscle atrophy. Although isoflavones, as potent antioxidative nutrients, have been known to reduce muscle damage during the catabolic state, the non-antioxidant effects of isoflavones against muscle atrophy are not well known. Here we report on the inhibitory effects of isoflavones such as genistein and daidzein on muscle atrophy caused by tumor necrosis factor (TNF)-α treatment. In C2C12 myotubes, TNF-α treatment markedly elevated the expression of the muscle-specific ubiquitin ligase MuRF1, but not of atrogin-1, leading to myotube atrophy. We found that MuRF1 promoter activity was mediated by acetylation of p65, a subunit of NFκB, a downstream target of the TNF-α signaling pathway; increased MuRF1 promoter activity was abolished by SIRT1, which is associated with deacetylation of p65. Of interest, isoflavones induced expression of SIRT1 mRNA and phosphorylation of AMP kinase, which is well known to stimulate SIRT1 expression, although there was no direct effect on SIRT1 activation. Moreover, isoflavones significantly suppressed MuRF1 promoter activity and myotube atrophy induced by TNF-α in C2C12 myotubes. These results suggest that isoflavones suppress myotube atrophy in skeletal muscle cells through activation of SIRT1 signaling. Thus, the efficacy of isoflavones could provide a novel therapeutic approach against inflammation-related muscle atrophy.


Asunto(s)
Glycine max/química , Isoflavonas/uso terapéutico , Fibras Musculares Esqueléticas/efectos de los fármacos , Proteínas Musculares/metabolismo , Atrofia Muscular/prevención & control , Fitoterapia , Sirtuina 1/metabolismo , Ubiquitina-Proteína Ligasas/metabolismo , Acetilación , Adenilato Quinasa/metabolismo , Animales , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Línea Celular , Inflamación/complicaciones , Inflamación/metabolismo , Inflamación/prevención & control , Isoflavonas/farmacología , Ratones , Fibras Musculares Esqueléticas/metabolismo , Proteínas Musculares/genética , Atrofia Muscular/metabolismo , FN-kappa B/metabolismo , Fosforilación , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Regiones Promotoras Genéticas , ARN Mensajero/metabolismo , Proteínas Ligasas SKP Cullina F-box/metabolismo , Transducción de Señal , Sirtuina 1/genética , Factor de Transcripción ReIA/metabolismo , Proteínas de Motivos Tripartitos , Factor de Necrosis Tumoral alfa/metabolismo , Factor de Necrosis Tumoral alfa/farmacología , Ubiquitina-Proteína Ligasas/genética
3.
Nature ; 458(7234): 106-9, 2009 Mar 05.
Artículo en Inglés | MEDLINE | ID: mdl-19262675

RESUMEN

In-cell NMR is an isotope-aided multi-dimensional NMR technique that enables observations of conformations and functions of proteins in living cells at the atomic level. This method has been successfully applied to proteins overexpressed in bacteria, providing information on protein-ligand interactions and conformations. However, the application of in-cell NMR to eukaryotic cells has been limited to Xenopus laevis oocytes. Wider application of the technique is hampered by inefficient delivery of isotope-labelled proteins into eukaryote somatic cells. Here we describe a method to obtain high-resolution two-dimensional (2D) heteronuclear NMR spectra of proteins inside living human cells. Proteins were delivered to the cytosol by the pyrenebutyrate-mediated action of cell-penetrating peptides linked covalently to the proteins. The proteins were subsequently released from cell-penetrating peptides by endogenous enzymatic activity or by autonomous reductive cleavage. The heteronuclear 2D spectra of three different proteins inside human cells demonstrate the broad application of this technique to studying interactions and protein processing. The in-cell NMR spectra of FKBP12 (also known as FKBP1A) show the formation of specific complexes between the protein and extracellularly administered immunosuppressants, demonstrating the utility of this technique in drug screening programs. Moreover, in-cell NMR spectroscopy demonstrates that ubiquitin has much higher hydrogen exchange rates in the intracellular environment, possibly due to multiple interactions with endogenous proteins.


Asunto(s)
Espacio Intracelular/metabolismo , Resonancia Magnética Nuclear Biomolecular/métodos , Proteínas Recombinantes de Fusión/química , Animales , Permeabilidad de la Membrana Celular , Supervivencia Celular/efectos de los fármacos , Medición de Intercambio de Deuterio , Evaluación Preclínica de Medicamentos/métodos , Productos del Gen tat/genética , Productos del Gen tat/metabolismo , Células HeLa , Humanos , Inmunosupresores/química , Inmunosupresores/metabolismo , Inmunosupresores/farmacología , Unión Proteica , Pirenos/farmacología , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Proteína 1A de Unión a Tacrolimus/química , Proteína 1A de Unión a Tacrolimus/genética , Proteína 1A de Unión a Tacrolimus/metabolismo , Transfección , Ubiquitina/genética , Ubiquitina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA